Widely studied in experimental models, it shows potential for skeletal muscle hypertrophy, cognitive function, regenerative medicine, and sports performance research
Some individuals may experience digestive side effects when starting GLP-1 therapy, including nausea, bloating, early fullness, constipation, or loose stools
TB-500 has a molecular weight of approximately 4963.44 g/mol and a CAS number of 77591-33-4
20 October 2025 by Konstanze Richter Novo Nordisk markets various versions of semaglutide, including Ozempic, Wegovy and Rybelsus K-KStock/ADOBE Stock Novo Nordisks EP 3 746 111 B1 protects a new formulation that leads to better bioavailability of the active ingredient in the tablet form of the drug. Several opponents had challenged the patent due to lack of inventive step
The choice of alternative depends on the severity of the reaction, the patient's weight loss goals, comorbidities, and individual risk-benefit assessment